20th Annual NATA Symposium

20th Annual NATA Symposium, Berlin 2019The 20th Annual NATA Symposium on Patient Blood Management, Haemostasis and Thrombosis took place on April 4-5, 2019 in Berlin, Germany.

This year, 580 delegates from 38 countries participated in the symposium and there was a record local attendance of 167 attendees from Portugal.

Download the NATA Conference App, “NATA Forum”, on the App Store or the Play Store to access presentation webcasts.

The Abstract Book can be downloaded here.

Please click on the link below for more information
20th Annual Symposium General Information

Follow NATA on LinkedIn and Twitter

Join NATA's group on LinkedIn and follow NATA on Twitter (@NATAforum) to receive the latest news on patient blood management, haemostasis and thrombosis, and to participate in discussions with colleagues in the field.
LinkedIn Group / Twitter


From the Literature

Sep 26, 2018

Published: Jun 2018

Myles PS, Bellomo R, Corcoran T, et al.

Restrictive versus liberal fluid therapy for major abdominal surgery.
N Engl J Med 2018;378:2263-2274.

#

NATA REVIEW:
This article has the potential to influence or even to change current clinical fluid therapy during surgery,...
REVIEW by:
C. von Heymann

Published: Jun 2018

Goel R, Patel EU, Cushing MM, et al.

Association of perioperative red blood cell transfusions with venous thromboembolism in a North American registry.
JAMA Surg 2018; Jun 13 [Epub ahead of print].

#

NATA REVIEW:
An association between red blood cell (RBC) transfusion and increased incidence of perioperative complications...
REVIEW by:
D. Faraoni

Published: May 2018

Sprigg N, Flaherty K, Appleton JP, et al.

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.
Lancet 2018;391:2107-2115.

#

NATA REVIEW:
This paper shows that tranexamic acid given up to 8 hours after primary intracerebral haemorrhage reduced haematoma...
REVIEW by:
B. H. Hunt

Published: Apr 2018

Roubinian NH, Hendrickson JE, Triulzi DJ, et al.

Contemporary risk factors and outcomes of transfusion-associated circulatory overload.
Crit Care Med 2018;46:577-585.

#

NATA REVIEW:
Recently, a joint working group of members of the International Haemovigilance Network, the International Society...
REVIEW by:
C. So-Osman

Published: Mar 2018

Hassan K, Bayer N, Schlingloff F, et al.

Bleeding complications after use of novel oral anticoagulants in patients undergoing cardiac surgery.
Ann Thorac Surg 2018;105:702-708.

#

NATA REVIEW:
The authors evaluated 81 patients treated with non-vitamin K oral anticoagulants (NOACs) who underwent...
REVIEW by:
J. H. Levy

Published: Jan 2018

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40,138 bleeding patients.
Lancet 2018;391:125-132.

#

NATA REVIEW:
Antifibrinolytic treatment has been shown to be effective in reducing blood loss and transfusion requirements...
REVIEW by:
M. Levi